Skip to main content
CAMBIUM BIO LIMITED logo

CAMBIUM BIO LIMITED — Investor Relations & Filings

Ticker · CMB ISIN · AU0000327769 ASX Professional, scientific and technical activities
Filings indexed 504 across all filing types
Latest filing 2013-09-29 Annual Report
Country AU Australia
Listing ASX CMB

About CAMBIUM BIO LIMITED

https://www.cambium.bio

Cambium Bio Limited is a clinical-stage regenerative medicine company focused on developing innovative cellular therapies to treat unmet medical needs in ophthalmology and inflammatory diseases. The company's primary focus is on its lead candidate, EluRegen, a first-in-class topical biologic designed for the treatment of corneal epithelial defects and dry eye disease. Utilizing its proprietary technology platforms, the company aims to harness the regenerative potential of biologics to provide effective treatments for chronic conditions. In addition to its ophthalmic pipeline, the company maintains assets in the field of mesenchymal stem cell therapies, including Progenza, which targets osteoarthritis and neuropathic pain. The company emphasizes a data-driven approach to clinical development, seeking to improve patient outcomes through advanced tissue engineering and cell-based solutions.

Recent filings

Filing Released Lang Actions
Full Year Statutory Accounts 58 pages 1.2MB
Annual Report Classification · 100% confidence The document is titled 'Consolidated Financial Statements for the year ended 30 June 2013' and includes detailed sections such as Directors' Report, Auditor's Independence Declaration, Corporate Governance Statement, Consolidated Statement of Profit or Loss and other Comprehensive Income, Consolidated Statement of Financial Position, Statement of Changes in Equity, Cash Flows, Notes to the Financial Statements, Directors' Declaration, Independent Auditor's Report, and ASX Additional Information. It covers the full fiscal year ending 30 June 2013 and contains comprehensive financial data, operational review, directors' details, and auditor's report. The length is substantial (15,000 characters), indicating this is the full annual report rather than a brief announcement or certification. Therefore, this document fits the definition of an Annual Report (10-K equivalent). FY 2013
2013-09-29 English
Initial Director's Interest Notice 2 pages 88.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities and contracts, specifically for a director named Roger Aston. The content is focused on disclosure of personal shareholdings and interests of a company director, which aligns with insider trading or director dealings disclosures. The document length is 2772 characters, which is short and focused on director share transactions. Therefore, this document fits the category of Director's Dealing (DIRS).
2013-09-23 English
Initial Director's Interest Notice 2 pages 88.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including registered holdings, interests not registered, and interests in contracts. The content is a formal notification of a director's personal share transactions or holdings. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is short and focused solely on director interests, confirming it is not a full financial report or other type of filing.
2013-09-23 English
Initial Director's Interest Notice 2 pages 94.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including the number and class of shares held by the director, and notes about contracts. This is a formal notification of a director's personal share transactions or holdings. The document length is short (2764 characters) and it is clearly a report of a director's dealings in shares, not a general regulatory filing or announcement. Therefore, it fits the category of Director's Dealing (DIRS).
2013-09-23 English
Initial Director's Interest Notice 2 pages 101.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including shares and options held directly and indirectly, and notes the absence of contracts related to the director's interests. This type of document is a formal notification of personal share transactions or holdings by a company director. It does not contain financial performance data, management discussion, or other report content. The document length is short (2949 characters) and is clearly a director's dealing notice. Therefore, the appropriate classification is Director's Dealing (DIRS).
2013-09-23 English
Initial Director's Interest Notice 2 pages 102.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the securities holdings and interests of a director named John Martin, including shares and options held directly and indirectly. There is no financial performance data, earnings information, or report publication mentioned. The content is focused on disclosure of personal share transactions and holdings by a company director, which aligns with the definition of Director's Dealing filings.
2013-09-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.